Yunnan-ADARC HIV Prevention Program: Developing and Testing a Model to Implement and Sustain PrEP Delivery in China.

云南-ADARC HIV 预防项目:开发和测试在中国实施和维持 PrEP 实施的模型。

基本信息

  • 批准号:
    10082934
  • 负责人:
  • 金额:
    $ 66.82万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-06-21 至 2024-04-30
  • 项目状态:
    已结题

项目摘要

7. Project Abstract Pre-exposure prophylaxis (PrEP), a key biomedical HIV prevention strategy, can significantly reduce HIV incidence in real-world settings. However, introduction and global scale-up of PrEP have been slow. Part of the challenge is that PrEP is typically introduced into existing health systems through a hit-or-miss process that is rarely studied. We propose the Yunnan-ADARC HIV Prevention Program, an implementation science study of the process of introduction and implementation of PrEP in a specific international health system facing high rates of HIV incidence among men who have sex with men. YAHPP will introduce and evaluate the implementation of PrEP among over 1000 men who have sex with men, in eight municipalities in Yunnan, China utilizing tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) donated by Gilead Sciences. The study is guided by the Stages of Implementation Completion Framework (SIC) and will use SIC- associated assessment tools to measure progression across eight pre-defined stages of implementation, including documenting costs and required resources. YAHPP has two specific aims: 1) To evaluate whether the addition of Enhanced implementation strategies to Standard health system PrEP delivery improves client-services outcomes; 2) To compare the time, costs, and resources required for Standard versus Enhanced PrEP implementation. Enhanced PrEP implementation will rely on a centralized technical assistance strategy to deliver PrEP-related knowledge, skills, and best practices to clinics delivering PrEP. The outcome of the study will be an implementation blueprint that may be used across China and in other low- and middle-income countries to guide the introduction of PrEP into existing health systems.
7. 项目摘要

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Kathrine Meyers其他文献

Kathrine Meyers的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Kathrine Meyers', 18)}}的其他基金

The TAIL-PrEP Study: Acceptability and Feasibility of a Tailored Adherence Intervention for safe discontinuation of Long-acting PrEP
TAIL-PrEP 研究:安全停用长效 PrEP 的定制依从性干预措施的可接受性和可行性
  • 批准号:
    10700242
  • 财政年份:
    2023
  • 资助金额:
    $ 66.82万
  • 项目类别:
Yunnan-ADARC HIV Prevention Program: Developing and Testing a Model to Implement and Sustain PrEP Delivery in China.
云南-ADARC HIV 预防项目:开发和测试在中国实施和维持 PrEP 实施的模型。
  • 批准号:
    10159965
  • 财政年份:
    2019
  • 资助金额:
    $ 66.82万
  • 项目类别:

相似海外基金

Yunnan-ADARC HIV Prevention Program: Developing and Testing a Model to Implement and Sustain PrEP Delivery in China.
云南-ADARC HIV 预防项目:开发和测试在中国实施和维持 PrEP 实施的模型。
  • 批准号:
    10159965
  • 财政年份:
    2019
  • 资助金额:
    $ 66.82万
  • 项目类别:
COLUMBIA-ADARC-CORNELL AIDS CLINICAL TRIALS UNIT
哥伦比亚-阿达克-康奈尔艾滋病临床试验中心
  • 批准号:
    6626366
  • 财政年份:
    2000
  • 资助金额:
    $ 66.82万
  • 项目类别:
COLUMBIA-ADARC-CORNELL AIDS CLINICAL TRIALS UNIT
哥伦比亚-阿达克-康奈尔艾滋病临床试验中心
  • 批准号:
    6692982
  • 财政年份:
    2000
  • 资助金额:
    $ 66.82万
  • 项目类别:
COLUMBIA-ADARC AIDS CLINICAL TRIALS UNIT
哥伦比亚-ADARC 艾滋病临床试验中心
  • 批准号:
    6341741
  • 财政年份:
    2000
  • 资助金额:
    $ 66.82万
  • 项目类别:
COLUMBIA-ADARC AIDS CLINICAL TRIALS UNIT
哥伦比亚-ADARC 艾滋病临床试验中心
  • 批准号:
    6022181
  • 财政年份:
    2000
  • 资助金额:
    $ 66.82万
  • 项目类别:
COLUMBIA-ADARC-CORNELL AIDS CLINICAL TRIALS UNIT
哥伦比亚-阿达克-康奈尔艾滋病临床试验中心
  • 批准号:
    6488741
  • 财政年份:
    2000
  • 资助金额:
    $ 66.82万
  • 项目类别:
COLUMBIA-ADARC-CORNELL AIDS CLINICAL TRIALS UNIT
哥伦比亚-阿达克-康奈尔艾滋病临床试验中心
  • 批准号:
    7019766
  • 财政年份:
    2000
  • 资助金额:
    $ 66.82万
  • 项目类别:
COLUMBIA-ADARC-CORNELL AIDS CLINICAL TRIALS UNIT
哥伦比亚-阿达克-康奈尔艾滋病临床试验中心
  • 批准号:
    7150728
  • 财政年份:
    2000
  • 资助金额:
    $ 66.82万
  • 项目类别:
ADARC CENTER FOR AIDS RESEARCH: VACCINE & THERAPY
ADARC 艾滋病研究中心:疫苗
  • 批准号:
    6116179
  • 财政年份:
    1999
  • 资助金额:
    $ 66.82万
  • 项目类别:
ADARC PROGRAM PROJECT SIV & HIV VACCINE DEVELOPMENT
ADARC 计划 SIV 项目
  • 批准号:
    6116176
  • 财政年份:
    1999
  • 资助金额:
    $ 66.82万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了